Researcher biography

Rickard is an NHMRC Leadership 2 Fellow and esteemed nurse researcher. She has completed over 50 randomised controlled trials and focuses on preventing healthcare associated infections and other complications for people with central, peripheral, venous and arterial catheters. As a Registered Nurse, she specialized in acute and critical care, and then coordinated pharmaceutical and investigator-initiated ICU research at the Royal Brisbane and Women’s Hospital. Her PhD (QUT, 2004) studied the impact of the duration of intravascular administration set use on bloodstream infection. Rickard has consistently won funding from the Australian National Health and Medical Research Council (NHMRC) and Medical Research Future Fund (MRFF) since 2008. She is committed to mentoring and developing opportunities for nursing clinician researchers, with many going on to prestigious careers and externally funded fellowships. Her international projects include the largest ever vascular access study - The One Million Global peripheral intravenous catheter Study (OMG Study). Rickard established the Alliance for Vascular Access Teaching and Research (AVATAR) in 2007 as a mentoring network which has evolved into a mature multi-institutional investigator network of >100 nursing and medical clinicians, scientists, consumers, statisticians and health economists who undertake large randomized controlled trials and related work in partnership with hospitals in Australia and overseas. AVATAR also has a significant educational focus, with workshops, a Masters level course and a focus on PhD and postdoctoral researcher development. Professor Rickard's awards include induction into the Sigma Theta Tau International Nurse Researcher Hall of Fame in 2013, and election to the prestigious Australian Academy of Health and Medical Sciences in 2015. She has >300 publications in leading journals such as The Lancet.

Featured projects Duration
Reducing blood culture contamination with the use of a needleless blood draw device (PIVO Pro): An adaptive group sequential randomized controlled trial (the PIVO trial)
investigator-initiated grant from Becton, Dickinson and Company
Exploring Infection Risk Factors and Infection Prevention and Control Interventions for Acute Hospital Inpatients with Behavioural Disturbance, Secondary to Cognitive Dysfunction, substance use or psychosocial disadvantage
The Prince Charles Hospital Foundation PhD Scholarship 2025
Comparative effectiveness of interventions to prevent bloodstream infections in central venous catheters: The IVCare adaptive platform trial (IVCare)
National Health and Medical Research Council (NHMRC) Investigator grant (Award ID: 2016399) and Medical Research Future Fund (MRFF) 2023 Clinical Trials Activity grant (Award ID: 2035451)
Difficult Access Requires Thought, Training and Technology (DART3): Co-developing an ultrasound pathway for patients with difficult intravenous access
NHMRC partnership project grant 2019 (Award ID:1180193)
The REcognising and reSPONDing to patients with BloodStream Infection (RESPOND-BSI) Study
UQ Foundations Research Excellence Awards; NHMRC Investigator Grant
Establishing Global Consensus on Vascular Access Surveillance Definitions Through a Modified Delphi Process
Infusion Nurses Society
Evaluation of chlorhexidine caps for central line associated blood stream infection prevention in people needing haemodialysis: a pilot randomised control trial
NHMRC Investigator Leadership 2 Grant – Professor Claire Rickard
Subcutaneously anchored securement system versus a traditional sutureless securement device for prevention of Peripherally Inserted Central Catheter dislodgement: a randomised controlled trial
Darling Downs Health Hospital Foundation Grant
Characterisation of Intravascular Access Device (IVAD) Staphylococcus aureus Blood Stream Infection (SAB)
Healthcare-Associated Infection Tracking with Enhanced Connectivity and Health Informatics
Queensland Government
Reducing blood culture contamination with the use of a needleless blood draw device (PIVO Pro): An adaptive group sequential randomized controlled trial (the PIVO trial)
Becton, Dickinson and Company; Herston Infectious Diseased Institute (HeIDI)
Comparative effectiveness of Class II/III medical devices to prevent bloodstream infections in central venous access devices: The IVCare adaptive platform trial (IVCare)
National Health and Medical Research Council (NHMRC) Investigator grant (Award ID: 2016399) and Medical Research Future Fund (MRFF) 2023 Clinical Trials Activity grant (Award ID: 2035451)
Mortality, length of stay, and cost attributable to CRBSI and CLABSI in patients with a central venous catheter in an Australian tertiary hospital: a case-control study
Health care associated infection burden in Queensland, Australia
Queensland Government
Translating Healthcare-Associated Infection Prevention Research into Practice: Australian Hospitals Survey 2025
Just Say No to the Just in Case Cannula: An Implementation Science Trial
Medical Research Future Fund (MRFF) - Externally led by Monash University
REBUILD: Reducing the Burden of Healthcare Associated Infection Using a Learning Health Systems Approach
NHMRC 2024 Collaborations in Health Services Research
The Threshold for Platelets study: a prospective randomised trial to define the platelet count which critically ill patients should receive a platelet transfusion prior to an invasive procedure
Medical Research Future Fund – Clinical Trials Activity Initiative – 2023 International Clinical Trial Collaborations Grant Opportunity Round 1 (Award ID: 2031827)